Immunoreactivity for endothelial markers, such as CD31, erythroblast transformation-specific-related gene (ERG), and von Willebrand factor (vWF) helps to differentiate epithelioid angiosarcoma from epithelioid sarcoma [13]. The gene discussed is VWF; the disease is epithelioid hemangioendothelioma.